Proceedings of the International scientific and practical conference ―Science at the Frontier of Civilizations‖ (March 16-18, 2026) / Publisher website: www.naukainfo.com. – Helsinki, Finland, 2026. - 145 p.

13 6 Paz D.L., Kralovics R., and Skoda R.C. Genetic basis and molecular profiling in myeloproliferative neoplasms Blood (2023) 141 (16): 1909– 1921. https://doi.org/10.1182/blood.2022017578 7 Shaoming Xu, Youshan Zhang, Jie Tan, Caixia Liang. Advances in the Study of High-Risk Gene Mutations for Primary Myelofibrosis. Journal of Biosciences and Medicines , Vol.10 No.7, July 8, 2022 DOI: 10.4236/jbm.2022.107006 8 How H,JacquelineS.Garcia J.S., and Mullally A. Biology and therapeutic targeting of molecular mechanisms in MPNs. Bllod, Apr 2023. V 141, N 16, 1922–1933. doi: 10.1182/blood.2022017416 9 Tefferi A, Guglielmelli P, Lasho TL, et al. MIPSS70+ version 2.0: Mutation and Karyotype-Enhanced International Prognostic Scoring System for primary myelofibrosis. J Clin Oncol. 2018;36(17):1769–1770. doi: 10.1200/JCO.2018.78.9867.